Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
July 08, 2010
Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
Roche presents data from HPV Dx trial; Epigenomics launches Epi proLung BL Reflex Assay in Europe.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Epigenomics Preps for European Launch of RT-PCR Lung Cancer Dx after Clinical Trial Validation
June 24, 2010 / PCR Insider - Dx Focus: Roche CT/NG Test Gets FDA OK; Pinpoint Genomics and BioReference Labs Launch Cancer Assays
February 2, 2012 / PCR Insider - Gen-Probe Sees Specificity of Newly Approved HPV Test as Market Differentiator
November 3, 2011 / PCR Insider - Epigenomics Taps Synlab to Provide Colorectal Cancer Dx in Europe; Completes $44.2M Financing
April 8, 2010 / PCR Insider - FDA Approves Roche Test as CDx for Tarceva for Treating Certain NSCLC Patients
May 15, 2013 / GenomeWeb Daily News